Narayan AK, Gupta Y, Little BP, et al. - Because lung cancer screening using low‐dose chest computed tomography (LCS) has been documented to attenuate lung cancer mortality in randomized controlled trials, researchers used cross‐sectional survey data from the 2018 Behavioral Risk Factor Surveillance System (BRFSS) survey in order to calculate recent LCS use. The BRFSS is a nationally representative, cross‐sectional telephone survey including adults in the United States (response rate of about 50%). Questions about LCS eligibility and use in eight states were incorporated in the 2018 BRFSS survey. The percentage of participants (aged 55‐79 years with a smoking history of > 30 pack‐years) who stated undergoing LCS was estimated as the primary outcome. This study involved 26,910 participants, with 9.9% of them being eligible for LCS. Of these eligible patients, undergoing LCS was reported by 19.2%. A greater likelihood of receiving LCS was observed in retired patients, patients with personal physicians, and patients who did not finish a high school education. Findings revealed an increasing use of LCS, relative to previously published studies. However, among eligible participants, LCS use was low (19%).